Breast cancer and a proto-oncogene.
作者信息
Barnes D M
机构信息
Clinical Oncology Unit, Guy's Hospital, London.
出版信息
BMJ. 1989 Oct 28;299(6707):1061-2. doi: 10.1136/bmj.299.6707.1061.
Abstract
摘要
相似文献
1
Breast cancer and a proto-oncogene.乳腺癌与一种原癌基因。
BMJ. 1989 Oct 28;299(6707):1061-2. doi: 10.1136/bmj.299.6707.1061.
2
Proto-oncogene structure and breast cancer prognosis.原癌基因结构与乳腺癌预后
J Clin Oncol. 1987 Jul;5(7):993-5. doi: 10.1200/JCO.1987.5.7.993.
3
Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease.
J Clin Oncol. 1987 Jul;5(7):999-1006. doi: 10.1200/JCO.1987.5.7.999.
4
[Oncogenes and anti-oncogenes in breast cancer].[乳腺癌中的癌基因与抗癌基因]
Bull Cancer. 1989;76(7):677-87.
5
[Oncogenes and suppressor genes in breast cancer].[乳腺癌中的癌基因与抑癌基因]
Presse Med. 1993 Sep 11;22(26):1209-11.
6
Oncogenes and antioncogenes in human breast carcinoma.人类乳腺癌中的癌基因与抗癌基因。
Pathol Annu. 1992;27 Pt 1:321-42.
7
[Importance of oncogenes in tumors of the breast. Results, useful revaluation, perspectives].[癌基因在乳腺癌中的重要性。结果、有益的重新评估、前景]
Pathol Biol (Paris). 1990 Oct;38(8):773.
8
Oncogenes and tumour suppressor genes in breast cancer.乳腺癌中的癌基因与肿瘤抑制基因
Br J Hosp Med. 1993;50(9):529-36.
9
Immunohistochemical assessment of tumour behaviour and patient prognosis in human breast cancer.人乳腺癌中肿瘤行为和患者预后的免疫组织化学评估
Dis Markers. 1991 May-Aug;9(3-4):159-65.
10
Expression of oncogenes in human breast cancer specimens.癌基因在人类乳腺癌标本中的表达。
Anticancer Res. 1991 Jan-Feb;11(1):193-201.
引用本文的文献
1
p53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry.p53蛋白作为乳腺癌的预后指标：四种免疫组化抗体的比较
Br J Cancer. 1996 Jan;73(1):29-35. doi: 10.1038/bjc.1996.6.
2
C-erbB-2 immunostaining: problems with interpretation.C-erbB-2免疫染色：解读问题
J Clin Pathol. 1994 Sep;47(9):816-22. doi: 10.1136/jcp.47.9.816.
3
The prognostic value of c-erbB2 in primary breast carcinomas: a study on 942 cases.c-erbB2在原发性乳腺癌中的预后价值：一项942例病例的研究。
Breast Cancer Res Treat. 1995 Sep;35(3):283-91. doi: 10.1007/BF00665980.
4
Expression of epidermal growth factor receptor in breast carcinoma.表皮生长因子受体在乳腺癌中的表达。
J Clin Pathol. 1990 May;43(5):385-9. doi: 10.1136/jcp.43.5.385.
5
Expression of c-erbB-2 protein product in bladder cancer.c-erbB-2蛋白产物在膀胱癌中的表达。
Br J Cancer. 1990 Nov;62(5):764-5. doi: 10.1038/bjc.1990.375.
6
Transgenic oncogene mice. Tumor phenotype predicts genotype.转基因致癌基因小鼠。肿瘤表型可预测基因型。
Am J Pathol. 1991 Sep;139(3):495-501.
7
Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.突变型p53、c-erbB-2及表皮生长因子受体在人膀胱移行细胞癌中的表达
Br J Cancer. 1991 Jun;63(6):967-70. doi: 10.1038/bjc.1991.211.
8
Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma.与乳腺癌中c-erbB-2癌蛋白过表达相关的核及流式细胞术特征
Breast Cancer Res Treat. 1991 Dec;20(1):3-10. doi: 10.1007/BF01833351.
9
Immunohistochemical and other features of breast carcinomas presenting clinically compared with those detected by cancer screening.与癌症筛查检测出的乳腺癌相比，临床呈现的乳腺癌的免疫组织化学及其他特征。
Br J Cancer. 1991 Oct;64(4):780-4. doi: 10.1038/bjc.1991.398.
10
c-erbB-2 oncoprotein expression in primary and advanced breast cancer.原发性和晚期乳腺癌中c-erbB-2癌蛋白的表达
Br J Cancer. 1991 Mar;63(3):439-43. doi: 10.1038/bjc.1991.101.
本文引用的文献
1
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.人类乳腺癌：HER-2/neu癌基因扩增与复发及生存的相关性。
Science. 1987 Jan 9;235(4785):177-82. doi: 10.1126/science.3798106.
2
3
Amplification of c-erbB-2 and aggressive human breast tumors?c-erbB-2的扩增与侵袭性人类乳腺肿瘤？
Science. 1988 Jun 24;240(4860):1795-8. doi: 10.1126/science.3289120.
4
Cellular and molecular aspects of neoplastic progression in the mammary gland.
Eur J Cancer Clin Oncol. 1988 Jan;24(1):15-20. doi: 10.1016/0277-5379(88)90171-x.
5
Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.通过DNA流式细胞术预测淋巴结阴性乳腺癌患者的复发或生存情况。
N Engl J Med. 1989 Mar 9;320(10):627-33. doi: 10.1056/NEJM198903093201003.
6
Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.神经蛋白在乳腺癌中的过表达。与粉刺型导管原位癌相关及在II期乳腺癌中的预后价值有限。
N Engl J Med. 1988 Nov 10;319(19):1239-45. doi: 10.1056/NEJM198811103191902.
7
Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
Cancer Res. 1988 Mar 1;48(5):1238-43.
8
Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification.人乳腺癌中c-erbB-2癌蛋白的过表达：免疫组织学评估与基因扩增相关。
Lancet. 1987 Jul 11;2(8550):69-72. doi: 10.1016/s0140-6736(87)92736-x.
9
Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.人腺癌中c-erbB-2癌基因在体内的扩增
Lancet. 1986 Apr 5;1(8484):765-7. doi: 10.1016/s0140-6736(86)91782-4.
10
An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma.人乳腺癌中c-erbB-2表达的免疫组织化学评估
Br J Cancer. 1988 Oct;58(4):448-52. doi: 10.1038/bjc.1988.238.
Zotero 插件